THE BASIC PRINCIPLES OF MAKATUSSIN SYROP

mavorixafor will raise the stage or impact of codeine by impacting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a strong CYP2D6 inhibitor) is contraindicated with medicines that are highly dependent on CYP2D6 for clearance.Composition of Cough, The active material is codeine phosphate hemihydrate. Just about every ml of oral sol